🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel Capsule(s) Serving Size
150 Servings
Fat/Fatty Acid Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
13 Calorie(s)
Total Fat
2 Gram(s) (4% DV)
1500 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1500mg UL 3000mg

Other Ingredients

Gelatin Glycerin Water, Purified Mixed Tocopherols Natural Flavors

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Adults: take 1 softgel capsule per day, preferably with a meal. Intensive use: consult your physician.

⚠️ Warnings & Precautions

Warnings: If you are pregnant or nursing, or on medication, consult your physician before use.

Keep out of reach of children.

Contains: fish and soy.

🧪 Formulation Notes

Contains three times the Omega-3's as a standard fish oil softgel containing 300 mg per capsule.

Triple the omega-3s of standard fish oil

Supports heart, brain, eye and joint health Odorless and molecularly distilled to improve quality and purity

Triple strength 3x

Product of Australia

Additional Information

Store in a cool, dry place.

Product Details

DSLD Entry Date 2023-05-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Blackmores
DSLD ID 284059
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →